• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help Print
Product No EMEA/H/C/002640
Brand Name Cometriq
Nonproprietary Name cabozantinib
API cabozantinib
ATC Code L01XE
Indications Treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma.
Orphan Drug yes
Generics no
Marketing Authorization Holder Ipsen Pharma
Status Authorised(授权)
Authorization Date 2014-03-21
Version 27
Condition Approval no
Exceptions no
Biosimilar no
Details 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息)